Grants per year
- 1 - 25 out of 33 results
Search results
-
Active
The Unfolded Protein Response and Bile Acid Metabolism
Green, R. (PD/PI), Barish, G. D. (Co-Investigator) & Liu, X. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
12/15/24 → 11/30/28
Project: Research project
-
VA IPA for Richard Green
Pandolfino, J. E. (PD/PI) & Green, R. (Co-PD/PI)
Southern Arizona VA Health Care System
9/16/24 → 9/15/25
Project: Research project
-
Avoiding Cardiovascular Complications in Liver Transplantation through Novel Studies (ACCT NOW) in Hypertension
Hughes, D. L. (PD/PI) & Zhao, L. (Co-Investigator)
University of Texas Southwestern Medical Center, National Heart, Lung, and Blood Institute
8/15/24 → 5/31/27
Project: Research project
-
Prot #STU00220567: Assessing the Feasibility for Using a New Blood Test (Non-Ceruloplasmin Copper) to Measure Free Copper in Wilson’s Disease
Cheung, A.C.-W. (PD/PI)
7/30/24 → 7/30/27
Project: Research project
-
AcetaSTAT Validation and Commercialization
Ganger, D. R. (PD/PI)
ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC, National Institute of Diabetes and Digestive and Kidney Diseases
4/1/24 → 3/31/25
Project: Research project
-
Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism
Fang, D. (PD/PI) & Green, R. (Co-Investigator)
University of Virginia, National Institute of Diabetes and Digestive and Kidney Diseases
2/1/24 → 1/31/28
Project: Research project
-
: Prot #RNLC3132: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)
Cheung, A.C.-W. (PD/PI)
Quintiles, Inc., Salix Pharmaceuticals, Inc.
1/12/24 → 1/12/27
Project: Research project
-
Prot #337HNAS20011 (NATiV3): A Randomised, Double‐Blind, Placebo‐Controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients with Non‐Cirrhotic Non‐Alcoholic Steatohepa
Cheung, A.C.-W. (PD/PI)
Pharmaceutical Research Associates, Inc., Inventiva SAS
9/11/23 → 9/11/26
Project: Research project
-
The spectrum of cognitive impairment including Alzheimer's Disease and Related Dementias after liver transplantation
Ladner, D. P. (PD/PI), Bonakdarpour, B. (Co-Investigator) & Ganger, D. R. (Co-Investigator)
University of California, San Francisco, National Institute on Aging
9/1/23 → 5/31/28
Project: Research project
-
Project 4
Ahmed, A. U. (Co-Investigator), Ahmed, A. U. (Co-Investigator), Ganger, D. R. (Co-Investigator), Ganger, D. R. (Co-Investigator), Kumthekar, P. U. (Co-Investigator), Kumthekar, P. U. (Co-Investigator), Miska, J. M. (Co-Investigator), Miska, J. M. (Co-Investigator), Stupp, R. (Co-Investigator) & Stupp, R. (Co-Investigator)
8/1/23 → 7/31/28
Project: Research project
-
Transplant Surgery Scientist Training Program
Green, R. (PD/PI) & Ladner, D. P. (Co-PD/PI)
National Institute of Diabetes and Digestive and Kidney Diseases
7/1/23 → 6/30/28
Project: Research project
-
Ex-Vivo Bioengineered Technology To Unravel Dysfunction Due to Non-Alcoholic Steatohepatitis (NASH)
Green, R. (PD/PI)
University of Arizona, National Institute of Diabetes and Digestive and Kidney Diseases
7/1/23 → 4/30/27
Project: Research project
-
Prot #MGL‐3196‐19: A Randomized Double‐blind Placebo‐controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver‐related Outcomes in Patients with Well‐compensated (Child‐Pugh A) Non‐alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO‐NASH OUTC
Cheung, A.C.-W. (PD/PI)
INC Research, LLC, Synta Pharmaceuticals Corp.
5/23/23 → 5/23/26
Project: Research project
-
Prot #VLX-601: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (VANTAGE)
Boike, J. R. (PD/PI)
Premier Research International, LLC, Mirum Pharmaceuticals
11/16/22 → 11/16/25
Project: Research project
-
Immune Tolerance Network
Levitsky, J. (PD/PI) & Levitsky, J. (PD/PI)
Benaroya Research Institute at Virginia Mason, National Institute of Allergy and Infectious Diseases
9/1/22 → 1/31/28
Project: Research project
-
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
Duarte, A. (PD/PI) & Duarte, A. (PD/PI)
University of Pittsburgh, National Institute of Diabetes and Digestive and Kidney Diseases
9/1/22 → 5/31/26
Project: Research project
-
Prot #CM-101-PSC-101: A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Evaluating the Safety and Efficacy of CM-101 in Subjects with Primary Sclerosing Cholangitis - The Spring Study
Boike, J. R. (PD/PI)
Covance Inc., Chemomab Therapeutics Ltd.
7/19/22 → 7/19/25
Project: Research project
-
Prot #OCE-205-201: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Adaptive Dose-Ranging Study to Assess Safety and Efficacy of Intravenous OCE-205 in Adults Diagnosed with Cirrhosis with Ascites who have Developed Hepatorenal Syndrome-Acute
Ganger, D. R. (PD/PI)
CTI Clinical Trial and Consulting Services, Ocelot Bio, Inc.
5/20/22 → 5/20/25
Project: Research project
-
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial
Wolf, M. (PD/PI), Wolf, M. (PD/PI), Yoshino Benavente, J. N. (PD/PI), Cheung, A.C.-W. (Co-Investigator), Ladner, D. P. (Co-Investigator), Ladner, D. P. (Co-Investigator), Ladner, D. P. (Co-Investigator), Levitsky, J. (Co-Investigator) & Levitsky, J. (Co-Investigator)
University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases
5/19/22 → 4/30/25
Project: Research project
-
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort
Wolf, M. (PD/PI), Yoshino Benavente, J. N. (PD/PI), Yoshino Benavente, J. N. (PD/PI), Boike, J. R. (Co-Investigator), Boike, J. R. (Co-Investigator), Gershon, R. (Co-Investigator), Gershon, R. (Co-Investigator), Kim, M. (Co-Investigator) & Kim, M. (Co-Investigator)
University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases
5/4/22 → 2/28/27
Project: Research project
-
Prot#MGL-3196-18: A 52-Week, Phase 3 Open-Label Extension Study, with a Single-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAEST
Cheung, A.C.-W. (PD/PI), Flamm, S. L. (PD/PI), Kulik, L. M. (PD/PI) & Rinella, M. E. (PD/PI)
Pharmaceutical Research Associates, Inc., Synta Pharmaceuticals Corp.
2/16/22 → 2/16/25
Project: Research project
-
Prot #GSN000350: TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness
Ganger, D. R. (PD/PI)
Pharmaceutical Research Associates, Inc., Calliditas Therapeutics Suisse SA
2/14/22 → 2/14/25
Project: Research project